BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37664917)

  • 21. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
    Chen X; Jin J; Zheng L; Sheng Y; Sun J
    J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways.
    Jiang HC; Chen XR; Sun HF; Nie YW
    Hum Cell; 2020 Jan; 33(1):175-184. PubMed ID: 31782107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
    Min WP; Wei XF
    Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
    Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway.
    Chen C; Shen Z
    Protein Pept Lett; 2023; 30(1):54-64. PubMed ID: 36278453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
    Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
    Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of Myc-associated zinc finger protein in malignant tumors.
    Zheng C; Wu H; Jin S; Li D; Tan S; Zhu X
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):506-514. PubMed ID: 35098656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
    Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
    Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
    Guo K; Wang J; Shu L; Zhou G
    Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-29b-3p Inhibits the Migration and Invasion of Gastric Cancer Cells by Regulating the Autophagy-Associated Protein MAZ.
    Zhao X; Ye N; Feng X; Ju H; Liu R; Lu W
    Onco Targets Ther; 2021; 14():3239-3249. PubMed ID: 34040389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathological significance of Golgi phosphoprotein 3 expression in papillary thyroid carcinoma].
    Huang DH; Jin L; Xie WW; Lin Q; Chen X
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2831-2835. PubMed ID: 31550811
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells.
    Sponziello M; Rosignolo F; Celano M; Maggisano V; Pecce V; De Rose RF; Lombardo GE; Durante C; Filetti S; Damante G; Russo D; Bulotta S
    Mol Cell Endocrinol; 2016 Aug; 431():123-32. PubMed ID: 27173027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2.
    Xia E; Bhandari A; Shen Y; Zhou X; Wang O
    Int J Oncol; 2018 Nov; 53(5):1927-1938. PubMed ID: 30106140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
    Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of SQSTM1 in papillary thyroid carcinoma and its influence on invasion, migration and proliferation of papillary thyroid cancer cells].
    Yu FQ; Liu CG; Ma RS; Zhang LL; Du GB; Niu DP; Yin DT
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):147-151. PubMed ID: 33455132
    [No Abstract]   [Full Text] [Related]  

  • 40. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.